UnitedHealth's fourth-quarter revenue missed Wall Street estimates on weakness in its health insurance business and the company also reported higher-than-expected annual medical costs.
This sent its shares down nearly 5% before the Wall Street bell today.
The company's results come a month after Brian Thompson, the CEO of UnitedHealth's insurance unit was killed, igniting a conversation over frustrations related to navigating the US health insurance system.
UnitedHealth's annual medical cost ratio - the percentage of premiums spent on medical care - rose to 85.5%, compared with 83.2% in 2023. Analysts were expecting a ratio of 84.96%, according to data compiled by LSEG.
Companies typically aim for a ratio close to around 80%, but the industry has been grappling with increased costs for nearly two years due to high demand for healthcare services under government-backed Medicare plans for older adults.
Shares of insurers CVS Health and Elevance Health also fell more than 3% in premarket trading.
Industry bellwether UnitedHealth has encountered a series of challenges during 2024, including a cyberattack on its tech division and a persistent increase in medical costs.
UnitedHealth reported revenue from premiums of $76.48 billion for the fourth quarter ended December 31, compared with estimates of $78.06 billion.
Overall revenue for the quarter came in at $100.81 billion, below expectations of $101.76 billion.
Revenue at its Optum healthcare services unit, which includes the pharmacy benefit business OptumRx, rose 9% to $65.1 billion.
On an adjusted basis, UnitedHealth earned $6.81 per share in the fourth quarter, compared with estimates of $6.72 per share.
The company reaffirmed its 2025 adjusted profit forecast of $29.50 to $30 per share, which it had initially provided in December.
